Zhanna Golodryga
appointed Zhanna Golodryga to the Board, effective as of April 1, 2025
Highest-materiality recent filing
AGCO Q1 net sales up 14.3% to $2.3B; adjusted EPS $0.94 vs $0.41; raises FY26 EPS outlook to ~$6.00
Net sales $2.3B +14.3% YoY; reported EPS $0.76, adjusted EPS $0.94 (vs $0.41 prior year).
All nine director nominees elected with strong support; Eric Hansotia received 63.8M for (85.7% of votes cast).
AGCO amends 2026 Annual Incentive Plan; updates metrics, targets, and adds clawback provision
CEO target set at 160% of salary; CFO at 100%; SVPs 70-90%; other participants 3-40%.
AGCO appoints James C. Collins Jr. to board; Matthew Tsien not standing for re-election
Board expanded to 10 directors; Collins appointed effective April 1, 2026, term expiring at 2026 annual meeting.
AGCO 2025 net sales down 13.5%; Q4 adjusted EPS beats; guides 2026 above 2025
Full year net sales $10.1B, down 13.5%; reported EPS $9.75 includes gain on TAFE sale.
AGCO files 2026 forms for restricted stock and performance share awards
Filed new Form of Restricted Stock Units Agreement for 2026 grants under 2006 Long-Term Incentive Plan.
AGCO Q3 adj EPS $1.35 vs $0.68 YoY; raises FY adj EPS outlook to ~$5.00
Net sales $2.5B, down 4.7% YoY; ex-currency and divestitures, down 8.4%.
AGCO completes sale of TAFE interest for $260M, after-tax proceeds ~$230M
Completed sale of ownership interest in TAFE to TAFE for $260 million aggregate consideration.
AGCO Q2 net sales down 18.8% to $2.6B; adjusted EPS $1.35 vs $2.53 a year ago
Reported EPS of $4.22 includes items from G&P divestiture; adjusted EPS $1.35.
AGCO announces $1B share repurchase program after TAFE resolution
Board authorized up to $1 billion of common stock repurchases.
AGCO and TAFE extend letter agreement expiration to Nov 28, 2025
Extends Letter Agreement expiration from July 15, 2025 to Nov 28, 2025 or upon escrow deposit for buyback.
TAFE will repurchase AGCO's remaining shareholdings in TAFE for an aggregate $260 million.
Net sales $2.1B, down 30.0% YoY; reported EPS $0.14 vs $2.25 prior year.
AGCO recasts segment data to isolate divested Grain & Protein business for 2023-2024
Divested G&P business (GSI, AP, Cumberland, Cimbria, Tecno) sold to A-AG Holdco Ltd on Nov 1, 2024.
AGCO extends TAFE letter agreement to June 30, 2025; parties in advanced settlement talks
Amendment No. 2 extends expiration of Letter Agreement from April 24, 2025 to June 30, 2025.
AGCO annual meeting approves all proposals; director Pörksen faces notable opposition
All nine director nominees elected, with Niels Pörksen receiving 59.8M for and 9.2M against.
AGCO appoints Zhanna Golodryga to Board of Directors effective April 1, 2025
Zhanna Golodryga appointed to AGCO Board, effective April 1, 2025.
AGCO 2024 adjusted EPS $7.50, sales down 19.1%; guides 2025 EPS $4.00-$4.50
Net sales $11.7B in 2024, down 19.1% YoY; reported EPS $(5.69) (includes impairment, restructuring, loss on Grain & Protein sale).
AGCO files 2025 forms of RSU and Performance Share Agreements
Form RSU agreement covers installment vesting; Retirement defined as age 65 or age 55 with 10 years' service for Senior VPs.
AGCO targets 14-15% op margin by 2029; 2025 outlook: sales ~$9.6B, EPS $4-$4.50
By 2029, targets: adjusted operating margins 14%-15%, outgrow industry by 4-5% annually, FCF conversion 75-100%.
AGCO SVP Bob Crain to retire Dec 31 after 19 years; oversaw Grain & Protein divestiture
Robert B. Crain, SVP and GM of Grain & Protein, will retire effective December 31, 2024.
Amendment effective Jan 1, 2025; expands eligibility to US-based VP, SVP+ roles.
AGCO Q3 net sales fall 24.8% to $2.6B, adjusted EPS $0.68; reaffirms 9% margin target
Q3 net sales $2.6B, down 24.8% YoY; reported EPS $0.40 vs $3.74; adjusted EPS $0.68 vs $3.97.
AGCO completes $700M divestiture of Grain & Protein business to American Industrial Partners
All-cash transaction valued at ~$700M closed November 1, 2024.
AGCO reports Q2 adjusted EPS $2.53 vs $4.29 YoY; lowers 2024 guidance to ~$8.00
Net sales $3.2B, down 15.1% YoY; reported EPS $(4.92) includes estimated loss on Grain & Protein held for sale.
AGCO sells Grain & Protein business to AIP for $700M; expects $450-$475M loss
Purchase price $700M in cash; 8.3x adjusted EBITDA multiple (TTM as of March 31, 2024).
AGCO initiates restructuring; $150-200M termination costs, up to 6% workforce cut
One-time termination benefits of $150M-$200M, mostly cash severance and benefits.
AGCO appoints Indira Agarwal as VP and Chief Accounting Officer, effective June 17, 2024
Indira Agarwal, age 48, to become VP & Chief Accounting Officer and Principal Accounting Officer on June 17, 2024.
AGCO Q1 EPS falls to $2.25; announces $2.50 special dividend; closes PTx Trimble JV
Net sales $2.9B (-12.1% YoY); reported EPS $2.25, adjusted EPS $2.32 (vs $3.10/$3.51 Q1 2023).
appointed Zhanna Golodryga to the Board, effective as of April 1, 2025
succeeding Damon Audia who has served in that role since September 2023. Mr. Audia will continue to serve in his role as Senior Vice President and Chief Financial Officer.
On May 16, 2024, AGCO Corporation (the “Company”) reported that Indira Agarwal was appointed Vice President and Chief Accounting Officer of the Company, effective June 17, 2024 (the “Effective Date”).
Max materiality 0.85 · Median 0.65 · Most common event other_material